The Prevalence of Insomnia in Patients With Psychiatric Disorders

NCT05408013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 427

Last updated 2026-04-03

No results posted yet for this study

Summary

The primary aim of the proposed project is to investigate the prevalence of insomnia in patients with psychiatric disorders treated as inpatients in psychiatric hospitals in two study sites in Switzerland and nine study sites in Germany. The secondary aim is to investigate whether there are demographic or disorder specific parameters that influence the prevalence of insomnia in patients with psychiatric disorders.

Conditions

Sponsors & Collaborators

  • Universitätsklinikum Freiburg Klinik für Psychiatrie und Psychotherapie

    collaborator UNKNOWN
  • Universitätsklinikum Schleswig-Holstein Klinik für Psychiatrie und Psychotherapie

    collaborator UNKNOWN
  • Schlafzentrum Pfalzklinikum Klingenmünster

    collaborator UNKNOWN
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie Leipzig

    collaborator UNKNOWN
  • Zentralinstitut für Seelische Gesundheit Mannheim

    collaborator OTHER
  • Privatklinik Meiringen

    collaborator UNKNOWN
  • Universitätsklinik für Psychiatrie und Psychotherapie, PMU Nürnberg

    collaborator UNKNOWN
  • LWL-Klinik Paderborn

    collaborator UNKNOWN
  • Klinik für Psychiatrie und Psychotherapie der Universität Regensburg

    collaborator UNKNOWN
  • Kompetenzzentrum Schlafmedizin Charité - Campus Benjamin Franklin

    collaborator UNKNOWN
  • Klinikum Ingolstadt (withdrawal of participation)

    collaborator UNKNOWN
  • University of Bern

    lead OTHER

Principal Investigators

  • Christoph Nissen, Prof. Dr. med · Sleep Research in Psychiatry

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05408013 on ClinicalTrials.gov